6 reports

Engages in the development of drugs for HIV/ AIDS, liver diseases, hematology, oncology, cardiovascular, inflammation, respiratory, and other therapies.

  • Cystic Fibrosis
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Royalty Pharma Acquires Royalties on Cystic Fibrosis Treatments from Cystic Fibrosis Foundation Therapeutics for USD3.3 Billion

It offers its approved products in the therapeutic areas of rheumatoid arthritis (RA), Crohn' s disease, diabetes, chronic kidney disease, HIV/ AIDS and others.

  • Cystic Fibrosis
  • United States
  • Company
  • Company Financials
  • RP Management LLC
  • ROYALTY PHARMA ACQUIRES ROYALTIES ON CYSTIC FIBROSIS TREATMENTS FROM CYSTIC FIBROSIS FOUNDATION THERAPEUTICS FOR USD3.3 BILLION

It offers its approved products in the therapeutic areas of rheumatoid arthritis (RA), Crohn' s disease, diabetes, chronic kidney disease, HIV/ AIDS and others.

  • Cystic Fibrosis
  • Pharmaceutical
  • United States
  • Company
  • Cystic Fibrosis Foundation Therapeutics, Inc.

HIV-Associated Lung Infections and Complications (Lung HIV) Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)(LHIV) GDCT## NCT##, ##R##HL##-##S##; ## Respiratory Human Immunodeficiency Virus (HIV) Infections

  • Anti-Infective
  • Clinical Trial
  • Cystic Fibrosis
  • World
  • Product Initiative
  • Apr 10, 2017: Research Uncovers Potential New Treatment to Treat and Stop Progression of Cystic Fibrosis

This disease is especially prevalent in HIV/ AIDS populations.

  • Cystic Fibrosis
  • Healthcare
  • Pharmaceutical
  • United States
  • GlobalData's company
  • CYSTIC FIBROSIS - PIPELINE BY GLAXOSMITHKLINE PLC, H1 2017
  • CYSTIC FIBROSIS - PIPELINE BY GILEAD SCIENCES INC, H1 2017

The company offers products in various therapeutic areas including cardiovascular, respiratory, inflammation, liver diseases, cancer and HIV/ AIDS.

  • Cystic Fibrosis
  • Pharmaceutical
  • United States
  • Product Initiative
  • Galapagos NV